Tel Aviv University scientists have engineered the successful Israel-invented CAR-T cell therapy (see here) to also treat other cancers. They discovered a subset of immune system T cells (known as CD4+ T cells) will attract antibodies on solid tumors and … Continue reading →

Israelis donated 1,567units of blood in one day at the Magen David Adom station at the Samaria Regional Division. They broke the previous Israeli record of 740 units in a 2014 Tel Aviv session. Donors included residents and soldiers from … Continue reading →

Scientists at Israel’s Weizmann Institute working with researchers in Germany have identified two antibodies that are effective in stopping one species of the Ebola virus. Research is ongoing to developing a multi-species vaccine. https://www.israel21c.org/experimental-ebola-vaccine-offers-long-term-protection/

A team of Israeli (Weizmann Institute) and British scientists have devised a blood test that analyzes activity of three enzymes (OGG1, MPG and APE1) connected to DNA damage. They say it can “significantly improve current lung cancer risk prediction, assisting … Continue reading →

As reported previously (Sep 2018) Israel’s Orasis has developed CSF-1 (eye drops) to treat presbyopia – age-related far-sightedness. Results of Phase 2b trials of CSF-1 showed “significant improvement”, together with “exceptional safety and tolerability”. https://www.orasis-pharma.com/orasis-pharmaceuticals-announces-csf-1-eye-drop-successfully-met-primary-endpoint-in-phase-2b-clinical-study-in-presbyopia/

Researchers at Israel’s Technion Institute have used artificial intelligence and big data to decode the unique signatures of certain cancer cells. The resulting technology – dubbed a “computerized pathologist” –could significantly boost development of personalized cancer treatments. https://www.israel21c.org/deep-learning-tech-reveals-personal-id-of-cancer-cells/